Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 aTyr PharmaTitan PharmaceuticalsVicalGenetic TechnologiesAevi Genomic Medicine
SymbolNASDAQ:LIFENASDAQ:TTNPNASDAQ:VICLNASDAQ:GENENASDAQ:GNMX
Price Information
Current Price$2.90$0.22$1.10$1.45$0.17
52 Week RangeBuyBuyN/AN/AN/A
Analyst Ratings
Consensus RecommendationBuyBuyN/AN/AN/A
Consensus Price Target$8.75$1.00N/AN/AN/A
% Upside from Price Target201.72% upside357.04% upsideN/AN/AN/A
Trade Information
Market Cap$9.96 million$14.85 million$15.44 million$7.88 million$12.89 million
Beta2.250.790.323.041.13
Average Volume143,6576,954,9231,444,12281,4863,164,141
Sales & Book Value
Annual Revenue$420,000.00$3.61 million$1.62 million$20,000.00N/A
Price / Sales26.864.0415.51355.25N/A
CashflowN/AN/AN/AN/AN/A
Price / CashN/AN/AN/AN/AN/A
Book Value$5.40 per share$0.53 per share$1.82 per share$0.26 per share$0.12 per share
Price / Book0.540.410.605.58N/A
Profitability
Net Income$-23,600,000.00$-9,020,000.00$-16,250,000.00$-4,600,000.00$-30,770,000.00
EPS($7.03)($0.72)($0.81)N/A($0.50)
Trailing P/E RatioN/AN/AN/A0.00N/A
Forward P/E RatioN/AN/A
P/E GrowthN/AN/AN/AN/AN/A
Net MarginsN/A-455.77%-1,002.10%N/AN/A
Return on Equity (ROE)-87.85%-962.95%-29.46%N/A-898.31%
Return on Assets (ROA)-52.86%-210.06%-27.85%N/A-286.73%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio0.11%N/AN/A0.05%N/A
Current Ratio2.47%1.13%36.84%2.95%0.65%
Quick Ratio2.47%0.76%36.84%2.90%0.65%
Ownership Information
Institutional Ownership Percentage49.48%2.89%29.06%2.72%7.03%
Insider Ownership Percentage27.70%1.40%4.58%N/A43.80%
Miscellaneous
Employees422330N/A14
Shares Outstanding3.89 million66.58 million22.84 million4.90 million77.71 million
Next Earnings Date5/11/2020 (Estimated)5/20/2020 (Estimated)N/AN/AN/A
OptionableOptionableOptionableOptionableOptionableOptionable

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel